Original Research
Accepted on 08 Aug 2025
Mathematical Modeling of the Effect of Early Detection in Breast Cancer Treatment
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1626435
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,454 articles
Review
Accepted on 08 Aug 2025
MicroRNAs in Breast Cancer-New Frontiers in Diagnosis, Targeted Therapy, and Prognosis Assessment
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1529907
Review
Accepted on 08 Aug 2025
Pharmacologic Management of HR+/HER2-mBC: A Clinically Oriented Review
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1596634
Original Research
Accepted on 07 Aug 2025
Tissue Expander Breast Reconstruction Outcomes following Postmastectomy Radiation Therapy in the Era of Neoadjuvant Chemotherapy
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1636472
- 125 views
Systematic Review
Published on 07 Aug 2025
The efficacy and immune-mediated safety of PD-1/PD-L1 combined with neoadjuvant chemotherapy in triple-negative breast cancer: a meta-analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1635418
- 251 views
Original Research
Published on 06 Aug 2025
Clinical study of 99mTc-Rituximab combined with dyes double tracing for axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1568550
- 330 views
Original Research
Published on 06 Aug 2025
Analysis of methylation features associated with neoadjuvant efficacy in HER2-positive breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1610093
- 345 views
Original Research
Published on 05 Aug 2025
SPOCK1 promotes the progression of breast cancer by modulating cancer-associated fibroblasts and exerts a synergistic effect with ANXA2
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1619171
- 396 views
Review
Published on 04 Aug 2025
Liquid biopsy in TNBC: significance in diagnostics, prediction, and treatment monitoring
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1607960
- 771 views
Original Research
Published on 04 Aug 2025
Effects of immersive virtual therapy on psychological and physical wellbeing in women with breast cancer at different stages of disease and treatment conditions: an experimental comparative study
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1581604
- 503 views
Correction
Published on 01 Aug 2025
Correction: Neoadjuvant chemotherapy with or without metformin in early-stage or locally advanced (non-metastatic) triple negative breast cancer—an open-label phase 2 randomized controlled trial
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1658958
- 388 views
Original Research
Published on 01 Aug 2025
Efficacy and safety of biosimilar trastuzumab (HLX02) in patients with HER2-positive advanced breast cancer: a retrospective real-world analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1622854
- 668 views
Original Research
Accepted on 31 Jul 2025
Pregnancy after breast cancer treatment in young patients
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1656429
- 122 views
Original Research
Accepted on 31 Jul 2025
Synergistic Antiproliferative and Pro-Apoptotic Effects of Prunus armeniaca and Bee Venom on Breast Cancer Cells
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1647710
- 309 views
Original Research
Accepted on 31 Jul 2025
Spatial gene expression profiling identifies prognostic features of residual tumors after neoadjuvant chemotherapy in triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1638758
- 150 views
Original Research
Accepted on 31 Jul 2025
Comprehensive Dosimetric Comparison of Halcyon 3.0 versus TrueBeam for Breast Cancer Volumetric Modulated Arc Therapy Plans
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1630702
- 132 views